Glen Eagle Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171K Sell
1,448
-1,783
-55% -$220K 0.02% 280
2025
Q4
$407K Sell
3,231
-890
-22% -$116K 0.06% 194
2025
Q3
$603K Sell
4,121
-315
-7% -$47.6K 0.08% 158
2025
Q2
$692K Sell
4,436
-4,718
-52% -$748K 0.11% 122
2025
Q1
$1.51M Buy
9,154
+485
+6% +$80.7K 0.25% 75
2024
Q4
$1.41M Buy
8,669
+1,034
+14% +$185K 0.23% 78
2024
Q3
$1.49M Sell
7,635
-157
-2% -$28.9K 0.25% 72
2024
Q2
$1.35M Buy
7,792
+1,422
+22% +$237K 0.25% 72
2024
Q1
$1.08M Buy
6,370
+692
+12% +$130K 0.2% 92
2023
Q4
$1.12M Buy
5,678
+4,021
+243% +$712K 0.23% 86
2023
Q3
$288K Buy
1,657
+405
+32% +$73.5K 0.07% 192
2023
Q2
$216K Buy
1,252
+41
+3% +$7.09K 0.05% 222
2023
Q1
$202K Buy
1,211
+44
+4% +$7.21K 0.05% 222
2022
Q4
$171K Sell
1,167
-343
-23% -$50.8K 0.05% 232
2022
Q3
$224K Sell
1,510
-368
-20% -$61.5K 0.07% 204
2022
Q2
$323K Sell
1,878
-2,721
-59% -$471K 0.09% 173
2022
Q1
$867K Sell
4,599
-250
-5% -$49.4K 0.23% 96
2021
Q4
$1.18M Buy
4,849
+324
+7% +$71K 0.31% 74
2021
Q3
$879K Buy
4,525
+1,353
+43% +$273K 0.25% 82
2021
Q2
$591K Buy
3,172
+872
+38% +$151K 0.18% 117
2021
Q1
$375K Buy
2,300
+1,670
+265% +$265K 0.13% 137
2020
Q4
$104K Buy
630
+345
+121% +$56.1K 0.04% 229
2020
Q3
$47.1K Sell
285
-3
-1% -$461 0.02% 315
2020
Q2
$39.5K Hold
288
0.02% 324
2020
Q1
$33.9K Sell
288
-96
-25% -$12.6K 0.02% 316
2019
Q4
$50.8K Buy
384
+47
+14% +$5.84K 0.03% 310
2019
Q3
$42K Buy
337
+57
+20% +$6.88K 0.03% 302
2019
Q2
$31.8K Buy
280
+2
+0.7% +$209 0.02% 335
2019
Q1
$28K Sell
278
-2
-0.7% -$182 0.02% 336
2018
Q4
$24K Hold
280
0.02% 340
2018
Q3
$25.6K Hold
280
0.02% 338
2018
Q2
$23.9K Buy
280
+130
+87% +$11K 0.02% 345
2018
Q1
$12.5K Hold
150
0.01% 408
2017
Q4
$10.8K Hold
150
0.01% 418
2017
Q3
$9.56K Hold
150
0.01% 438
2017
Q2
$9.36K Hold
150
0.01% 401
2017
Q1
$8.01K Hold
150
0.01% 404
2016
Q4
$8.03K Buy
+150
New +$7.63K 0.01% 390

Other funds holding ZTS

Glen Eagle Advisors's ZTS Position: Q1 2026 in Review

Glen Eagle Advisors reduced its Zoetis (ZTS) stake by 55% in Q1 2026, selling an estimated $220K and leaving 1,448 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #280.

Glen Eagle Advisors first reported a position in ZTS in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.51M in Q1 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Glen Eagle Advisors held 1,448 shares of Zoetis worth $171K as of Q1 2026.
  • Glen Eagle Advisors sold 1,783 Zoetis shares in Q1 2026, an estimated $220K.
  • Zoetis made up 0.02% of Glen Eagle Advisors's portfolio in Q1 2026, its #280 holding.
  • Glen Eagle Advisors first reported a position in Zoetis in Q4 2016 and has held it in 38 quarters since.
  • Glen Eagle Advisors's Zoetis position peaked at $1.51M in Q1 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.